Literature DB >> 25743813

Expression and prognostic implications of FOXO3a and Ki67 in lung adenocarcinomas.

Hong-Bin Liu1, Xiang-Xiang Gao, Qing Zhang, Jian Liu, Yuan Cui, Yan Zhu, Yi-Fei Liu.   

Abstract

To investigate the significance of FOXO3a and Ki67 in human lung adenocarcinomas. Envision immunohistochemical staining and Western blotting were used to examine the protein expression of FOXO3a in 127 cases of human lung adenocarcinoma specimens. The positive rate in lung adenocarcinoma (55.9%) was lower than that in normal tissues (80%). We found that the expression of FOXO3a was closely related with the degree of differentiation, TNM staging, lymph node metastasis and survival. In addition, significant differences in the different pathological types of lung adenocarcinoma cases (P<0.01). The FOXO3a positive rate of the acini as the main type (APA) (86.7%) and the lepidic as the main type (LPA) (82.4%) was higher than the solid as the main type (SPA) (50.0%), the papilla as the main type (PPA) (42.9%) and the micropapilla as the main type (MPA) (9.4%). Moreover, the expression of FOXO3a was negatively related with Ki67 expression. Our results suggested that the expression of FOXO3a is closely correlated with the aggressiveness of lung adenocarcinoma. It was indicated that disregulation of FOXO3a might play key roles in the occurrence and development of lung adenocarcinoma and joint detection of the two markers might play an important role in diagnosing tumors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25743813     DOI: 10.7314/apjcp.2015.16.4.1443

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.

Authors:  Xiaoli Li; Jian Liu; Li Qian; Honggang Ke; Chan Yao; Wei Tian; Yifei Liu; Jianguo Zhang
Journal:  Mol Cell Biochem       Date:  2018-01-11       Impact factor: 3.396

2.  Ki-67 is overexpressed in human laryngeal carcinoma and contributes to the proliferation of HEp2 cells.

Authors:  Yanxia Bai; Yuan Shao; Huajing Li; Wanli Xue; Fang Quan; Shengli Wu
Journal:  Oncol Lett       Date:  2016-08-08       Impact factor: 2.967

Review 3.  FOXO3 on the Road to Longevity: Lessons From SNPs and Chromatin Hubs.

Authors:  Paola Sanese; Giovanna Forte; Vittoria Disciglio; Valentina Grossi; Cristiano Simone
Journal:  Comput Struct Biotechnol J       Date:  2019-06-13       Impact factor: 7.271

4.  MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3.

Authors:  Ziyi Yin; Wenyan Wang; Gengbao Qu; Lin Wang; Xiang Wang; Qin Pan
Journal:  Thorac Cancer       Date:  2020-02-26       Impact factor: 3.500

5.  Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling.

Authors:  Jiahui Wu; Xiao He; Ziwei Xiong; Lingyu Shi; Daofeng Chen; Yulin Feng; Quan Wen
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

6.  Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.

Authors:  Li Jun Yang; Qing Tang; Jingjing Wu; Yuqing Chen; Fang Zheng; Zhenhui Dai; Swei Sunny Hann
Journal:  J Exp Clin Cancer Res       Date:  2016-03-31

Review 7.  Critical role of FOXO3a in carcinogenesis.

Authors:  Ying Liu; Xiang Ao; Wei Ding; Murugavel Ponnusamy; Wei Wu; Xiaodan Hao; Wanpeng Yu; Yifei Wang; Peifeng Li; Jianxun Wang
Journal:  Mol Cancer       Date:  2018-07-25       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.